Escalation and De-Escalation Strategies for Endocrine Therapy in Early-Stage Breast Cancer
Tamer Al-Batsh,1 Nayef Abdel-Razeq,2 Yosra Al-Masri,1 Osama El-Khatib,1 Baha Sharaf,1 Faris Tamimi,1 Hikmat Abdel-Razeq1,3 1Section of Hematology and Medical Oncology, Department of Internal Medicine, King Hussein Cancer Center, Amman, 11941, Jordan; 2Department of Hematology and Medical Oncology, M...
Saved in:
| Main Authors: | Al-Batsh T, Abdel-Razeq N, Al-Masri Y, El-Khatib O, Sharaf B, Tamimi F, Abdel-Razeq H |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-03-01
|
| Series: | Biologics: Targets & Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/escalation-and-de-escalation-strategies-for-endocrine-therapy-in-early-peer-reviewed-fulltext-article-BTT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Escalation of adjuvant endocrine therapy for early hormone-dependent HER2-negative breast cancer: to whom, when and why?
by: I. V. Kolyadina
Published: (2024-05-01) -
Update in the clinical utilization of chemoprevention for breast cancer: a narrative review
by: Razan Mansour, et al.
Published: (2025-06-01) -
A meta-analysis and systematic review of different cyclin-dependent kinase 4/6 inhibitors in breast cancer
by: Jialin Zhang, et al.
Published: (2025-03-01) -
Lesson from a metastatic male breast cancer case: CDK4/6 plus aromatase inhibitors could not exceed tamoxifen
by: Tala Najdi, et al.
Published: (2025-05-01) -
Investigation of ribociclib, abemaciclib and palbociclib resistance in ER+ breast cancer cells reveal potential therapeutic opportunities
by: Mashael Algethami, et al.
Published: (2025-08-01)